NORADRENALINE (NOREPINEPHRINE) 0.1 Mg/Ml Irland - engelsk - HPRA (Health Products Regulatory Authority)

noradrenaline (norepinephrine) 0.1 mg/ml

martindale pharmaceuticals ltd - noradrenaline acid tartrate - 0.1 mg/ml

ADRENALINE AUTO INJECT SUN 300 adrenaline (epinephrine) 300 microgram/0.3mL solution for injection auto-injector syringe Australien - engelsk - Department of Health (Therapeutic Goods Administration)

adrenaline auto inject sun 300 adrenaline (epinephrine) 300 microgram/0.3ml solution for injection auto-injector syringe

sun pharma anz pty ltd - adrenaline (epinephrine), quantity: 0.3 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium metabisulfite; hydrochloric acid - for the emergency treatment of anaphylaxis (acute severe allergic reactions) due to insect stings, or bites, foods, drugs or other allergens.

ADRENALINE AUTO INJECT JR SUN 150 adrenaline (epinephrine) 150 microgram/0.3mL solution for injection auto-injector syringe Australien - engelsk - Department of Health (Therapeutic Goods Administration)

adrenaline auto inject jr sun 150 adrenaline (epinephrine) 150 microgram/0.3ml solution for injection auto-injector syringe

sun pharma anz pty ltd - adrenaline (epinephrine), quantity: 0.15 mg - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; hydrochloric acid; water for injections - for the emergency treatment of anaphylaxis (acute severe allergic reactions) due to insect stings, or bites, foods, drugs or other allergens.

Bupivacaine 25mg/10ml (0.25%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

bupivacaine 25mg/10ml (0.25%) / adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules

0.25%) / adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules (advanz pharma - bupivacaine hydrochloride; adrenaline acid tartrate - solution for injection - 2.5mg/1ml ; 5microgram/1ml

Bupivacaine 50mg/10ml (0.5%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

bupivacaine 50mg/10ml (0.5%) / adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules

0.5%) / adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules (advanz pharma - bupivacaine hydrochloride; adrenaline acid tartrate - solution for injection - 5mg/1ml ; 5microgram/1ml

2% XYLOCAINE DENTAL WITH ADRENALINE 1:80,000 2.2mL injection cartridge Australien - engelsk - Department of Health (Therapeutic Goods Administration)

2% xylocaine dental with adrenaline 1:80,000 2.2ml injection cartridge

dentsply sirona pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 22.7 microgram/ml (equivalent: adrenaline (epinephrine), qty 12.5 microgram/ml); lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium metabisulfite; sodium hydroxide - indications as at 25 july 2003 : lidocaine (lignocaine) solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lidocaine (lignocaine) solutions with adrenaline (epinephrine) are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

NORADRENALINE AGUETTANT 1MGML CONCENTRATE FOR SOLUTION FOR INFUSION Singapore - engelsk - HSA (Health Sciences Authority)

noradrenaline aguettant 1mgml concentrate for solution for infusion

aguettant asia pacific pte. ltd. - noradrenaline tartrate 2mg/ml equiv. noradrenaline - infusion, solution concentrate - noradrenaline tartrate 2mg/ml equiv. noradrenaline 1mg/ml

DBL™ Adrenaline Injection BP New Zealand - engelsk - Medsafe (Medicines Safety Authority)

dbl™ adrenaline injection bp

pfizer new zealand limited - adrenaline acid tartrate 1.8mg equivalent to 1:1000 or 1 mg/ml adrenaline - solution for injection - 1:1000 - active: adrenaline acid tartrate 1.8mg equivalent to 1:1000 or 1 mg/ml adrenaline excipient: sodium chloride sodium metabisulfite water for injection - for the treatment of acute allergic reactions, life-threatening angioneurotic oedema, and anaphylactic shock resulting from reactions to drugs, animal serums, insect stings and other allergens.

DBL™ Adrenaline Injection BP New Zealand - engelsk - Medsafe (Medicines Safety Authority)

dbl™ adrenaline injection bp

pfizer new zealand limited - adrenaline acid tartrate 1.8mg equivalent to 1:10000 or 1 mg/10ml adrenaline - solution for injection - 1:10000 - active: adrenaline acid tartrate 1.8mg equivalent to 1:10000 or 1 mg/10ml adrenaline excipient: sodium chloride sodium metabisulfite water for injection - for the treatment of acute allergic reactions, life-threatening angioneurotic oedema, and anaphylactic shock resulting from reactions to drugs, animal serums, insect stings and other allergens.